On variations of the brightness of type Ia supernovae with the age of the host stellar population

Recent observational studies of type Ia supernovae (SNeIa) suggest correlations between the peak brightness of an event and the age of the progenitor stellar population. This trend likely follows from properties of the progenitor white dwarf (WD), such as central density, that follow from properties of the host stellar population. We present a statistically well-controlled, systematic study utilizing a suite of multi-dimensional SNeIa simulations investigating the influence of central density of the progenitor WD on the production of Fe-group material, particularly radioactive Ni-56, which powers the light curve. We find that on average, as the progenitor's central density increases, production of Fe-group material does not change but production of Ni-56 decreases. We attribute this result to a higher rate of neutronization at higher density. The central density of the progenitor is determined by the mass of the WD and the cooling time prior to the onset of mass transfer from the companion, as well as the subsequent accretion heating and neutrino losses. The dependence of this density on cooling time, combined with the result of our central density study, offers an explanation for the observed age-luminosity correlation: a longer cooling time raises the central density at ignition thereby producing less Ni-56 and thus a dimmer event. While our ensemble of results demonstrates a significant trend, we find considerable variation between realizations, indicating the necessity for averaging over an ensemble of simulations to demonstrate a statistically significant result.Comment: 5 pages, 4 figures, 1 table, accepted to ApJ

Making Sense of the Legendre Transform

The Legendre transform is an important tool in theoretical physics, playing a critical role in classical mechanics, statistical mechanics, and thermodynamics. Yet, in typical undergraduate or graduate courses, the power of motivation and elegance of the method are often missing, unlike the treatments frequently enjoyed by Fourier transforms. We review and modify the presentation of Legendre transforms in a way that explicates the formal mathematics, resulting in manifestly symmetric equations, thereby clarifying the structure of the transform algebraically and geometrically. Then we bring in the physics to motivate the transform as a way of choosing independent variables that are more easily controlled. We demonstrate how the Legendre transform arises naturally from statistical mechanics and show how the use of dimensionless thermodynamic potentials leads to more natural and symmetric relations.Comment: 11 pages, 3 figure

Epistemic Two-Dimensionalism and Arguments From Epistemic Misclassification

According to Epistemic Two-Dimensional Semantics (E2D), expressions have a counterfactual intension and an epistemic intension. Epistemic intensions reflect cognitive significance such that sentences with necessary epistemic intensions are a priori. We defend E2D against an influential line of criticism: arguments from epistemic misclassification. We focus in particular on the arguments of Speaks [2010] and Schroeter [2005]. Such arguments conclude that E2D is mistaken from (i) the claim that E2D is committed to classifying certain sentences as a priori, and (ii) the claim that such sentences are a posteriori. We aim to show that these arguments are unsuccessful as (i) and (ii) undercut each other. One must distinguish the general framework of E2D from a specific implementation of it. The framework is flexible enough to avoid commitment to the apriority of any particular sentence; only specific implementations are so committed. Arguments from epistemic misclassification are therefore better understood as arguments for favouring one implementation of E2D over another, rather than as refutations of E2D

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study

<p>Abstract</p> <p>Background</p> <p>Pneumococcal polysaccharide vaccine (PPV) is recommended for all adults 65 years of age and older and for younger adults with high-risk conditions. While data from national surveys provide information on the proportion of adults 65 years of age and older reporting ever receipt of PPV they do not collect more detailed information, such as age at vaccination or the total number of vaccinations received. In addition, there is relatively little information available on PPV coverage in younger adults with chronic conditions. To assess contemporary patterns of pneumococcal vaccination and revaccination of adults, we conducted a cross-sectional study of adults enrolled in medical care organizations (MCOs) participating in the Vaccine Safety Datalink project.</p> <p>Methods</p> <p>The study population included 1.5 million adults 25 years of age and older enrolled in the four participating MCOs on December 1, 2006. PPVs administered to members of the study population prior to that date were identified from computerized immunization registries maintained by the MCOs.</p> <p>Results</p> <p>Among the general population of adults 25 through 64 years of age, vaccine coverage increased from 2% in the 25–29 year old age-group to 26% in the 60–64 year old age-group. In all age-groups, coverage was substantially higher in persons defined as having a chronic high risk condition. This was particularly true for diabetes mellitus, with vaccine coverage of over 50% in the lower age-groups and 75% in those 60–64 years of age. Among adults 65 years of age and older, 82% had received at least one PPV and 18% had received two or more PPVs.</p> <p>Conclusion</p> <p>We found higher levels of PPV coverage among adults 65 years of age and older and among younger adults with diabetes mellitus than reported by national surveys and for those groups PPV coverage approached the <it>Healthy People 2010 </it>national objectives. These results suggest that achieving those objectives for PPV is possible and that high vaccination coverage may be facilitated by vaccine tracking and reminder systems.</p

Clinical ROC Studies of Digital Stereo Mammography

The objective of this study was to explore and document the diagnostic utility of digital stereo mammography for the detection of localized breast cancer in women. In it we character­ized the ability of experienced mammographers, general radiologists, and non-radiologists to detect three types of tumor masses embedded within a heterogeneous background of normal tis­sue elements in numerically simulated digital mammograms. The simulated mammograms were displayed to the subjects on a high resolution video display, both in stereo mode and in mono mode. Half of the mammograms contained a single tumor, ranging from 0.3 to 0.8 cm in maxi­mal diameter. Each reader rated 120 images (60 in stereo and 60 in mono) as to the probability of abnormality on scale of 1-5. Observer responses were evaluated using receiver operating characteristic (ROC) analysis to characterize any difference in diagnostic performance between the two viewing modes. The synthesized mammograms and the digital display were highly rated by the participant radiologists as promising tools for future research. The results of ROC analysis, however, indicated no significant difference in tumor detection when the same readers utilized the stereo mode versus the mono mode (Az mono = 0.833 versus, Az stereo = 0.826). The results were similar for readers of all 3 experience levels--mammographers, general radiolo­gists, and non-radiologists

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab.

PurposeWe hypothesized that bortezomib, an agent that suppresses HIF-1α transcriptional activity, when combined with bevacizumab, would obviate the HIF-1α resistance pathway. The objectives of this phase I trial were to assess safety and biological activity of this combination.Experimental designPatients with advanced, refractory malignancies were eligible. Patients received bevacizumab and bortezomib (3-week cycle) with dose expansions permitted if responses were seen and for assessing correlates. Pharmacodynamic assessment included plasma VEGF, VEGFR2, 20S proteasome inhibition, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and HIF-1α tumor expression.ResultsNinety-one patients were treated (median=6 prior treatments). The FDA-approved doses of both drugs were safely reached, and the recommended phase 2 dose (RP2D) is bevacizumab 15 mg/kg with bortezomib 1.3 mg/m(2). Four patients attained partial response (PR) and seven patients achieved stable disease (SD) ≥ 6 months (Total SD ≥ 6 months/PR=11 (12%)). The most common drug-related toxicities included thrombocytopenia (23%) and fatigue (19%). DCE-MRI analysis demonstrated no dose-dependent decreases in K(trans) although analysis was limited by small sample size (N=12).ConclusionCombination bevacizumab and bortezomib is well-tolerated and has demonstrated clinical activity in patients with previously treated advanced malignancy. Pharmacodynamic assessment suggests that inhibition of angiogenic activity was achieved

Evaluating Systematic Dependencies of Type Ia Supernovae: The Influence of Deflagration to Detonation Density

We explore the effects of the deflagration to detonation transition (DDT) density on the production of Ni-56 in thermonuclear supernova explosions (type Ia supernovae). Within the DDT paradigm, the transition density sets the amount of expansion during the deflagration phase of the explosion and therefore the amount of nuclear statistical equilibrium (NSE) material produced. We employ a theoretical framework for a well-controlled statistical study of two-dimensional simulations of thermonuclear supernovae with randomized initial conditions that can, with a particular choice of transition density, produce a similar average and range of Ni-56 masses to those inferred from observations. Within this framework, we utilize a more realistic "simmered" white dwarf progenitor model with a flame model and energetics scheme to calculate the amount of Ni-56 and NSE material synthesized for a suite of simulated explosions in which the transition density is varied in the range 1-3x10^7 g/cc. We find a quadratic dependence of the NSE yield on the log of the transition density, which is determined by the competition between plume rise and stellar expansion. By considering the effect of metallicity on the transition density, we find the NSE yield decreases by 0.055 +/- 0.004 solar masses for a 1 solar metallicity increase evaluated about solar metallicity. For the same change in metallicity, this result translates to a 0.067 +/- 0.004 solar mass decrease in the Ni-56 yield, slightly stronger than that due to the variation in electron fraction from the initial composition. Observations testing the dependence of the yield on metallicity remain somewhat ambiguous, but the dependence we find is comparable to that inferred from some studies.Comment: 15 pages, 13 figures, accepted to ApJ on July 6, 201